ban the use of phenylpropanolamine in OTC products
Experts are now urging the FDA to ban the use of phenylpropanolamine in OTC products.
This is due to a possible increased risk of hemorrhagic stroke in young women using appetite suppressants...and patients taking cough and cold products that contain phenylpropanolamine (PPA).
Caution patients not to exceed recommended doses of PPA-containing products...Acutrim, Dexatrim, Contac, Dimetapp, etc.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote